Breast Cancer Clinical Trial
Implementation of the Families Accelerating Cascade Testing Toolkit (FACTT) for Hereditary Breast and Ovarian Cancer and Lynch Syndrome
Summary
The purpose of this research study is to learn how cancer care providers can help their patients communicate the need for genetic testing in families with inherited cancer syndromes.
Eligibility Criteria
Inclusion Criteria:
Documentation of HBOC or Lynch-associated "pathogenic/ likely pathogenic" mutation per American College of Medical Genetics and Genomics criteria (1)
Diagnosis of one or more invasive cancers: epithelial ovarian, fallopian tube, primary peritoneal, breast, colorectal, endometrial
Mutation listed in NCCN guidelines with at least Category 2A evidence for intervention
Over the age of 18
Psychological ability and general health that permits completion of study requirements and follow-up
Willingness to complete follow-up surveys in person, electronically, or by telephone for up to 6 months
Exclusion Criteria:
-"Variant of undetermined significance," "likely benign" or "benign" variant per ACMGG criteria
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Saint Louis Missouri, 63110, United States More Info
Principal Investigator
Sub-Investigator
Sub-Investigator
Sub-Investigator
How clear is this clinincal trial information?